Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Maggi

Showing results (31-40 of 469) with videos related to

Pageof 47
Sort By:
Reviews in Endocrine & Metabolic Disorders|November 7, 2015
The role of prolactin in andrology: what is new?Giulia Rastrelli, Giovanni Corona, Mario Maggi
Asian Journal of Andrology|August 20, 2019
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?Giulia Rastrelli, Linda Vignozzi, Mario Maggi
European Urology|June 20, 2012
Re: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25Mauro Gacci, Mario Maggi, Marco Carini
European Urology|May 20, 2008
Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44Mauro Gacci, Marco Carini, Mario Maggi
Expert Review of Clinical Pharmacology|March 6, 2018
Pharmacological management of late-onset hypogonadismGiulia Rastrelli, Mario Maggi, Giovanni Corona
The World Journal of Men'S Health|May 13, 2017
Testosterone Replacement Therapy: Long-Term Safety and EfficacyGiovanni Corona, Alessandra Sforza, Mario Maggi
Endocrine Connections|November 30, 2020
Pheochromocytoma/paraganglioma preclinical models: which to use and why?Serena Martinelli, Mario Maggi, Elena Rapizzi
Sexual Medicine|December 26, 2017
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation AvanafilGiovanni Corona, Mario Maggi, Emmanuele A Jannini
The Journal of Sexual Medicine|January 14, 2020
Testosterone Therapy: What We Have Learned From TrialsGiovanni Corona, Luiz Otavio Torres, Mario Maggi
The Journal of Sexual Medicine|October 5, 2011
Evaluation of premature ejaculationEmmanuele A Jannini, Mario Maggi, Andrea Lenzi
Pageof 47

Showing results (31-40 of 469) with videos related to

Sort By:
Pageof 47
Reviews in Endocrine & Metabolic Disorders|November 7, 2015
The role of prolactin in andrology: what is new?Giulia Rastrelli, Giovanni Corona, Mario Maggi
Asian Journal of Andrology|August 20, 2019
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?Giulia Rastrelli, Linda Vignozzi, Mario Maggi
European Urology|June 20, 2012
Re: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25Mauro Gacci, Mario Maggi, Marco Carini
European Urology|May 20, 2008
Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44Mauro Gacci, Marco Carini, Mario Maggi
Expert Review of Clinical Pharmacology|March 6, 2018
Pharmacological management of late-onset hypogonadismGiulia Rastrelli, Mario Maggi, Giovanni Corona
The World Journal of Men'S Health|May 13, 2017
Testosterone Replacement Therapy: Long-Term Safety and EfficacyGiovanni Corona, Alessandra Sforza, Mario Maggi
Endocrine Connections|November 30, 2020
Pheochromocytoma/paraganglioma preclinical models: which to use and why?Serena Martinelli, Mario Maggi, Elena Rapizzi
Sexual Medicine|December 26, 2017
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation AvanafilGiovanni Corona, Mario Maggi, Emmanuele A Jannini
The Journal of Sexual Medicine|January 14, 2020
Testosterone Therapy: What We Have Learned From TrialsGiovanni Corona, Luiz Otavio Torres, Mario Maggi
The Journal of Sexual Medicine|October 5, 2011
Evaluation of premature ejaculationEmmanuele A Jannini, Mario Maggi, Andrea Lenzi
Pageof 47